---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-24-000069"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:01:32.724526+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Avanos Medical appoints Indrani Franchini to Board of Directors, effective July 1, 2024

## Summary
- Appointment fills a vacancy; Franchini will serve on Audit and Compliance Committees.
- Compensation includes $70,000 annual cash retainer, $12,500 Audit, $7,500 Compliance, and $190,000 RSU grant.
- Board now comprises 6 directors (5 independent) with 3 women, 2 ethnically diverse.
- Franchini previously EVP/CLO at Alnylam, EVP/CCO at Alexion, and roles at Hess and Pfizer.

## SEC filing metadata
- accession: 0001606498-24-000069
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000069/0001606498-24-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000069/avns-20240628.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-24-000069
- JSON: https://secwatch.observer/filing/0001606498-24-000069.json
- Plain text: https://secwatch.observer/filing/0001606498-24-000069.txt

## Key facts
- Executive change
  Indrani Franchini was appointed as Director at AVANOS MEDICAL, INC..
  - Action: appointed
  - Role: Director
  source text: On June 28, 2024, the Board of Directors (the “Board”) of Avanos Medical, Inc. (the “Company”) appointed Indrani Franchini to the Board, effective July 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000069/0001606498-24-000069-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.